Sign of the times: telehealth firm's ad for weight-loss drugs to run during Super Bowl (by my colleague Katie Deighton): www.wsj.com/articles/him...

Breaking: Ozempic and Wegovy are among 15 drugs up for a new round of price negotiations by Medicare

JPMorgan is hosting its first major healthcare gathering since the death of UnitedHealthcare’s CEO Brian Thompson and security around industry leaders will be heavy

Got news tips for The Wall Street Journal? Here are some secure ways to send tips or documents, anonymously or otherwise: www.wsj.com/tips

Will Medicare and Medicaid broadly cover anti-obesity meds like Wegovy? Outgoing Biden administration proposes it, up to incoming Trump admin to keep or scrap it. W/ @lizessleywhyte.bsky.social : www.wsj.com/health/healt...

The tried-and-true pharma marketing methods--TV ads, sales reps, etc.--only go so far when it comes to weight loss drugs. That's why Lilly and Novo are sending reps to employers, to get more of them to cover the drugs. It's not an easy sell, because of the high cost: www.wsj.com/health/pharm...

I wrote about the increasing use of an unusual treatment for difficult depression, J&J's Spravato, a cousin of ketamine: www.wsj.com/health/healt...

Novo Nordisk's planned purchase of Catalent's manufacturing plants underscores the mismatch between demand and supply of popular new weight loss drugs: www.wsj.com/business/dea...